The store will not work correctly when cookies are disabled.
2-((4-Chlorobenzyl)sulfanyl)-5-(3-nitro-5-(trifluoromethyl)phenyl)-1,3,4-oxadiazole
ID: ALA4095835
PubChem CID: 137653153
Max Phase: Preclinical
Molecular Formula: C16H9ClF3N3O3S
Molecular Weight: 415.78
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: O=[N+]([O-])c1cc(-c2nnc(SCc3ccc(Cl)cc3)o2)cc(C(F)(F)F)c1
Standard InChI: InChI=1S/C16H9ClF3N3O3S/c17-12-3-1-9(2-4-12)8-27-15-22-21-14(26-15)10-5-11(16(18,19)20)7-13(6-10)23(24)25/h1-7H,8H2
Standard InChI Key: WKEPDXWOQWKSFD-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
3.4765 -12.1416 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0933 -12.6776 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8659 -12.4113 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0217 -11.6092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4049 -11.0732 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6322 -11.3394 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8095 -11.3260 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4803 -11.7926 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.1315 -11.2987 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8652 -10.5262 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.0496 -10.5262 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.9133 -11.5364 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
8.5100 -10.9781 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2920 -11.2157 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4771 -12.0116 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2590 -12.2493 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8557 -11.6910 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6706 -10.8950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8887 -10.6574 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6375 -11.9286 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
3.0119 -10.8018 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.2393 -11.0680 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.1677 -9.9996 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.9376 -13.4798 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1650 -13.7460 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
4.5544 -14.0158 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
3.7228 -14.2678 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
4 7 1 0
7 8 1 0
8 9 1 0
9 10 2 0
10 11 1 0
11 7 2 0
9 12 1 0
12 13 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
17 20 1 0
21 22 2 0
21 23 1 0
6 21 1 0
2 24 1 0
24 25 1 0
24 26 1 0
24 27 1 0
M CHG 2 21 1 23 -1
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 415.78 | Molecular Weight (Monoisotopic): 415.0005 | AlogP: 5.61 | #Rotatable Bonds: 5 |
Polar Surface Area: 82.06 | Molecular Species: NEUTRAL | HBA: 6 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 6 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 5.33 | CX LogD: 5.33 |
Aromatic Rings: 3 | Heavy Atoms: 27 | QED Weighted: 0.31 | Np Likeness Score: -2.24 |
References
1. Karabanovich G, Němeček J, Valášková L, Carazo A, Konečná K, Stolaříková J, Hrabálek A, Pavliš O, Pávek P, Vávrová K, Roh J, Klimešová V.. (2017) S-substituted 3,5-dinitrophenyl 1,3,4-oxadiazole-2-thiols and tetrazole-5-thiols as highly efficient antitubercular agents., 126 [PMID:27907875] [10.1016/j.ejmech.2016.11.041] |